Literature DB >> 25632921

A pilot study of fluorescent imaging of colorectal tumors using a γ-glutamyl-transpeptidase-activatable fluorescent probe.

Chiko Sato1, Seiichiro Abe, Yutaka Saito, Eriko So Tsuruki, Hiroyuki Takamaru, Makomo Makazu, Yoshinori Sato, Hayato Sasaki, Hirohito Tanaka, Nobuaki Ikezawa, Masayoshi Yamada, Taku Sakamoto, Takeshi Nakajima, Takahisa Matsuda, Ryoji Kushima, Mako Kamiya, Shin Maeda, Yasuteru Urano.   

Abstract

UNLABELLED: Backgrounds/Aim: Colorectal laterally spreading tumors (LSTs) are sometimes difficult to visualize even with image-enhanced endoscopy. γ-Glutamyl-transpeptidase (GGT) is a cell surface-associated enzyme that is overexpressed in various types of human cancers. Furthermore, GGT expression is higher in colorectal cancer cells than in normal colorectal mucosa. γ-Glutamyl hydroxymethyl rhodamine green (gGlu-HMRG), an activatable fluorescent probe, is nonfluorescent under a neutral pH and normal cellular environment; however, it turns highly fluorescent upon reaction with GGT. We evaluated ex vivo fluorescent imaging of colorectal LSTs using this GGT-activatable fluorescent probe.
METHODS: Between March 2013 and March 2014, 30 endoscopically resected colorectal LSTs were prospectively included in this study. Each was analyzed by first taking a baseline image before spraying, then spraying with gGlu-HMRG onto the freshly resected specimen, and finally taking fluorescent images 15 min after spraying with a dedicated imaging machine.
RESULTS: Of the LSTs, 67% rapidly showed positive fluorescent activity. These activities were shown in adenoma (54%) and carcinoma in adenoma (76%), and in LST-granular type (80%) and LST-nongranular type (40%).
CONCLUSION: Topically spraying gGlu-HMRG enabled rapid and selective fluorescent imaging of colorectal tumors owing to the upregulated GGT activity in cancer cells.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25632921     DOI: 10.1159/000369367

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  13 in total

Review 1.  Advances in fluorescent-image guided surgery.

Authors:  Mark J Landau; Daniel J Gould; Ketan M Patel
Journal:  Ann Transl Med       Date:  2016-10

2.  Feasibility of Using an Enzymatically Activatable Fluorescence Probe for the Rapid Evaluation of Pancreatic Tissue Obtained Using Endoscopic Ultrasound-Guided Fine Needle Aspiration: a Pilot Study.

Authors:  Kazumichi Kawakubo; Shunsuke Ohnishi; Yutaka Hatanaka; Kanako C Hatanaka; Hidetaka Hosono; Yoshimasa Kubota; Mako Kamiya; Masaki Kuwatani; Hiroshi Kawakami; Yasuteru Urano; Naoya Sakamoto
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

3.  Surgical tissue handling methods to optimize ex vivo fluorescence with the activatable optical probe γ-glutamyl hydroxymethyl rhodamine green.

Authors:  Toshiko Harada; Yuko Nakamura; Kazuhide Sato; Tadanobu Nagaya; Peter L Choyke; Yasuyuki Seto; Hisataka Kobayashi
Journal:  Contrast Media Mol Imaging       Date:  2016-07-22       Impact factor: 3.161

Review 4.  Activatable fluorescent probes in fluorescence-guided surgery: Practical considerations.

Authors:  Ai Mochida; Fusa Ogata; Tadanobu Nagaya; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioorg Med Chem       Date:  2017-12-05       Impact factor: 3.641

Review 5.  Fluorescence-Guided Surgery.

Authors:  Tadanobu Nagaya; Yu A Nakamura; Peter L Choyke; Hisataka Kobayashi
Journal:  Front Oncol       Date:  2017-12-22       Impact factor: 6.244

6.  Intraoperative imaging of hepatic cancers using γ-glutamyltranspeptidase-specific fluorophore enabling real-time identification and estimation of recurrence.

Authors:  Yoichi Miyata; Takeaki Ishizawa; Mako Kamiya; Suguru Yamashita; Kiyoshi Hasegawa; Aya Ushiku; Junji Shibahara; Masashi Fukayama; Yasuteru Urano; Norihiro Kokudo
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

7.  Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.

Authors:  Kyojiro Kawakami; Yasunori Fujita; Yoko Matsuda; Tomio Arai; Kengo Horie; Koji Kameyama; Taku Kato; Koichi Masunaga; Yutaka Kasuya; Masashi Tanaka; Kosuke Mizutani; Takashi Deguchi; Masafumi Ito
Journal:  BMC Cancer       Date:  2017-05-05       Impact factor: 4.430

8.  Rapid detection of papillary thyroid carcinoma by fluorescence imaging using a γ-glutamyltranspeptidase-specific probe: a pilot study.

Authors:  Rumi Hino; Naoko Inoshita; Toyoki Yoshimoto; Makiko Ogawa; Daishu Miura; Ryoko Watanabe; Kenta Watanabe; Mako Kamiya; Yasteru Urano
Journal:  Thyroid Res       Date:  2018-11-21

9.  Fluorescent imaging of superficial head and neck squamous cell carcinoma using a γ-glutamyltranspeptidase-activated targeting agent: a pilot study.

Authors:  Takeshi Mizushima; Shunsuke Ohnishi; Yuichi Shimizu; Yutaka Hatanaka; Kanako C Hatanaka; Hidetaka Hosono; Yoshimasa Kubota; Mitsuteru Natsuizaka; Mako Kamiya; Shouko Ono; Akihiro Homma; Mototsugu Kato; Naoya Sakamoto; Yasuteru Urano
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

10.  Dynamic fluorescent imaging with the activatable probe, γ-glutamyl hydroxymethyl rhodamine green in the detection of peritoneal cancer metastases: Overcoming the problem of dilution when using a sprayable optical probe.

Authors:  Yuko Nakamura; Toshiko Harada; Tadanobu Nagaya; Kazuhide Sato; Shuhei Okuyama; Peter L Choyke; Hisataka Kobayashi
Journal:  Oncotarget       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.